Depo-Provera meningioma lawsuit women are seeking justice after years of trusting a birth control injection that may have caused brain tumors. Thousands of women received Depo-Provera shots without adequate warnings about meningioma risk. These women now face life-altering diagnoses. Many underwent brain surgery. Others live with tumors that require constant monitoring. If you used Depo-Provera and developed a meningioma, you are not alone. Federal courts have consolidated these claims into a single litigation to hold Pfizer accountable.
Understanding Depo-Provera Meningioma Lawsuit Women: Why This Group Is at Risk
Depo-Provera contains depot medroxyprogesterone acetate (DMPA). This synthetic hormone is injected every three months to prevent pregnancy. Millions of women in the United States have used it since its approval in 1992. The drug works by suppressing ovulation through high-dose progesterone. Meningiomas are tumors that grow in the membranes surrounding the brain. These tumors have progesterone receptors. Prolonged exposure to synthetic progesterone may fuel their growth.
A September 2025 study published in JAMA Neurology confirmed what many suspected. Women who used Depo-Provera had a 2.43 times higher risk of meningioma. The risk increased dramatically with longer use. Women who used the injection for more than three years faced over three-fold increased odds. Those who started Depo-Provera after age 31 faced the highest risk. Even one year of use showed a 35 percent increase in meningioma odds.
Despite growing international evidence, the FDA did not update Depo-Provera’s label to include a meningioma warning until December 2025. France had already linked the drug to intracranial meningiomas in March 2024. Depo-Provera meningioma lawsuit women argue that Pfizer knew about this risk for years. They claim the company failed to warn patients and doctors. Women trusted this contraceptive with their health. Many feel that trust was betrayed.
Active Lawsuits Affecting This Group
Depo-Provera meningioma lawsuit women now have their claims centralized in federal court. The Judicial Panel on Multidistrict Litigation created MDL 3140 to handle these cases efficiently. As of April 2026, approximately 3,769 cases are pending. The litigation is housed in the Northern District of Florida. Judge M. Casey Rodgers oversees all proceedings.
The court has selected five pilot cases to test key legal issues before a jury. The first bellwether trial, Blonski v. Pfizer, is scheduled for December 7, 2026. General causation hearings are set for June 24 through 26, 2026. A Daubert hearing on scientific evidence occurred May 26 through 28. These proceedings will determine whether expert testimony on the Depo-Provera and meningioma connection can go before jurors.
| Detail | Information |
|---|---|
| MDL Number | 3140 |
| Court | Northern District of Florida |
| Judge | M. Casey Rodgers |
| Cases Pending | ~3,769 (April 2026) |
| Defendant | Pfizer Inc. |
| Injury Type | Meningioma (brain tumor) |
| First Bellwether Trial | December 7, 2026 |
| Pilot Cases | Toney, Blonski, Schmidt, Wilson, Arceo |
New cases continue to be filed and transferred into MDL 3140 each month. Depo-Provera meningioma lawsuit women who have not yet filed may still have time. However, statutes of limitations vary by state. Acting sooner rather than later protects your legal rights.
Eligibility and Evidence Requirements
Depo-Provera meningioma lawsuit women generally need to show two things. First, they used Depo-Provera injections. Second, they were later diagnosed with a meningioma. The strength of a case often depends on duration of use. Women who received injections for one year or longer typically have stronger claims. However, even shorter-term users may qualify depending on their circumstances.
Medical records are the foundation of your case. You will need records showing your Depo-Provera prescriptions and injection dates. Pharmacy records and insurance claims can also verify use. Your meningioma diagnosis records are equally critical. These include MRI or CT scans, pathology reports, and surgical records. Keep all records related to symptoms like headaches, vision changes, or seizures.
Depo-Provera meningioma lawsuit women should also gather records showing the timeline between drug use and diagnosis. Attorneys look for a clear connection between exposure and injury. If your doctor noted the contraceptive use in your tumor treatment records, that strengthens your claim. Women who had surgery to remove a meningioma may qualify for higher potential compensation than those with watchful-waiting diagnoses.
Step-by-Step: How to Check If You Qualify
Step one: Confirm your Depo-Provera use. Check with your gynecologist, primary care doctor, or clinic. Request prescription history from your pharmacy. Insurance companies also keep records of billed injections. Even if you used Depo-Provera years ago, these records typically exist in archived systems.
Step two: Document your meningioma diagnosis. Obtain copies of all imaging studies that detected the tumor. Get your neurosurgeon’s or neurologist’s records. If you had surgery, request the operative report and pathology results. Step three: Note your symptoms and how the tumor affected your daily life. Document lost work, medical expenses, and emotional impact.
Step four: Contact a qualified attorney who handles Depo-Provera meningioma lawsuit women cases. Most firms offer free case evaluations. They work on contingency, meaning no upfront costs. An experienced lawyer will review your records and determine whether you may qualify. Step five: File before your state’s statute of limitations expires. A licensed attorney can advise you on your specific deadline.
Financial Considerations and Timeline
Depo-Provera meningioma lawsuit women should understand the financial structure of these cases. Most mass tort attorneys work on contingency fees. This means you pay nothing unless your case results in compensation. Typical contingency fees range from 33 to 40 percent of any recovery. All case expenses are usually advanced by the law firm.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
No settlements have been announced as of May 2026. The litigation is still in its pretrial phase. The December 2026 bellwether trial will provide critical information about potential case values. Settlement negotiations often begin after early trial results become clear. Based on similar pharmaceutical litigation, individual cases could take two to four years from filing to resolution.
Potential compensation may cover medical bills, lost wages, pain and suffering, and diminished quality of life. Women who underwent craniotomy surgery may see higher valuations. Those with recurring tumors or permanent neurological effects may also qualify for additional damages. Every case is unique. Consult a licensed attorney to understand what your specific situation may be worth.
Finding the Right Attorney
Depo-Provera meningioma lawsuit women deserve attorneys who understand both the medicine and the law. Look for firms with specific experience in pharmaceutical mass torts. Ask whether they are actively involved in MDL 3140. Attorneys on the plaintiffs’ steering committee have the deepest knowledge of case developments.
During your consultation, ask how many Depo-Provera cases the firm currently handles. Ask about their communication practices and case timeline expectations. A good attorney will explain the process clearly without making promises about outcomes. They should never guarantee compensation. Be cautious of any firm that does.
Depo-Provera meningioma lawsuit women can find qualified attorneys through state bar associations. The American Association for Justice also maintains directories of mass tort lawyers. Many national firms handle cases regardless of which state you live in. The most important factor is choosing someone who will treat your case with the attention and empathy it deserves. You went through something serious. Your legal team should respect that.
Frequently Asked Questions
How long do I have to file a Depo-Provera meningioma lawsuit?
Statutes of limitations vary by state. Most range from two to four years from the date of diagnosis or discovery. Some states apply a “discovery rule” that starts the clock when you learn your tumor may be linked to Depo-Provera. Because the FDA warning was only added in December 2025, some women may have extended filing windows. Consult a licensed attorney immediately to determine your specific deadline.
Can I file a claim if I used Depo-Provera many years ago?
Yes. Many Depo-Provera meningioma lawsuit women used the injection in the 1990s or 2000s. What matters is when you were diagnosed with a meningioma and when you connected it to Depo-Provera use. Meningiomas are slow-growing tumors. They can take years or even decades to become symptomatic. Your attorney can evaluate whether your claim falls within the applicable time limit.
What if my meningioma was classified as benign?
Most meningiomas are technically benign. However, they still require medical intervention and cause serious harm. Many Depo-Provera meningioma lawsuit women had benign tumors that required brain surgery, radiation, or ongoing monitoring. A benign classification does not disqualify you from filing a claim. The key issue is whether Depo-Provera contributed to tumor development and whether you suffered harm as a result.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- New Jersey Tort Reform Guide
- North Carolina Tort Reform Guide
- New York Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.